Log in to save to my catalogue

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7cd90eff1b2743afa1500462c53fc72d

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

About this item

Full title

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

Publisher

Switzerland: MDPI AG

Journal title

Current oncology (Toronto), 2023-03, Vol.30 (3), p.3160-3175

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Lung cancer is the second-most commonly diagnosed cancer and the leading cause of cancer death worldwide. The most common histological type is non-small-cell lung cancer, accounting for 85% of all lung cancer cases. About one out of three new cases of non-small-cell lung cancer are diagnosed at a locally advanced stage—mainly stage III—consisting o...

Alternative Titles

Full title

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7cd90eff1b2743afa1500462c53fc72d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7cd90eff1b2743afa1500462c53fc72d

Other Identifiers

ISSN

1718-7729,1198-0052

E-ISSN

1718-7729

DOI

10.3390/curroncol30030239

How to access this item